| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/30/2005 | US6936628 Orally administering one or more pharmaceutically acceptable acid neutralizing buffers with epothiolones (simultaneously, before or after) to increase the vioavailability of epothiolones |
| 08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
| 08/30/2005 | US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof. |
| 08/30/2005 | US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 08/30/2005 | US6936602 Benzazepine derivatives, process for the preparation of the same and uses thereof |
| 08/30/2005 | US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups |
| 08/30/2005 | US6936592 antibiotics and antiprotozoa agents |
| 08/30/2005 | US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production |
| 08/30/2005 | US6936425 Attenuated salmonella SP12 mutants as antigen carriers |
| 08/30/2005 | US6936261 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 08/30/2005 | US6936259 For therapy and prophylaxis of bacterial infections |
| 08/30/2005 | US6936258 Staphylococcus antigen and vaccine |
| 08/30/2005 | US6936257 Recombinant Venezuelan equine encephalitis virus vaccine |
| 08/30/2005 | US6936255 adjuvant which is a preferential stimulator of TH1 cell response such as 3D-MPL and QS21 |
| 08/30/2005 | US6936250 Polysaccharide encapsualted antigen |
| 08/30/2005 | CA2136331C New pharmaceutical uses of krill enzymes |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/30/2005 | CA2063587C Stable vaccine compositions containing interleukins |
| 08/30/2005 | CA1341489C Family of primate hematopoietic growth factors |
| 08/27/2005 | CA2555803A1 Pneumolysin derivatives |
| 08/25/2005 | WO2005077948A1 Fungicidal heterocyclic compounds |
| 08/25/2005 | WO2005077900A1 Bicyclic amide derivatives |
| 08/25/2005 | WO2005077382A1 Prion growth inhibitor |
| 08/25/2005 | WO2005077379A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR |
| 08/25/2005 | WO2005010154A3 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/25/2005 | WO2005000850A3 Novel crystalline forms of valacyclovir hydrochloride |
| 08/25/2005 | WO2004108687A3 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 08/25/2005 | US20050187390 Bicyclic heteroaryl derivatives |
| 08/25/2005 | US20050187265 Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 08/25/2005 | US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints |
| 08/25/2005 | US20050187257 Methods of treating sepsis |
| 08/25/2005 | US20050187255 Novel curcumin analogues and uses thereof |
| 08/25/2005 | US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5) |
| 08/25/2005 | US20050187229 Crystalline forms of valacyclovir hydrochloride |
| 08/25/2005 | US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them |
| 08/25/2005 | US20050187226 A1 adenosine receptor antagonists |
| 08/25/2005 | US20050187185 for tautening skin, in particular for reducing the size of wrinkles in the facial region in a long-lasting manner; comprising crosslinked or uncrosslinked hyaluronic acid associated with heparin |
| 08/25/2005 | US20050187183 Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
| 08/25/2005 | US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection |
| 08/25/2005 | US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186563 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |
| 08/25/2005 | US20050186562 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 08/25/2005 | US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186161 Comprises neticonazole and a basic substance; high permeability into nail and also has high efficacy |
| 08/25/2005 | US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit |
| 08/25/2005 | DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy |
| 08/25/2005 | CA2555507A1 Use of proton pump inhibitors for the treatment of cancer conditions |
| 08/25/2005 | CA2555503A1 Humanized anti-cd3 bispecific binding molecules having reduced immunogenicity, uses and compositions relating thereto |
| 08/25/2005 | CA2555366A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 08/25/2005 | CA2555253A1 Compositions of pamps and listeria monocytogenes and methods of use |
| 08/25/2005 | CA2555176A1 Hiv integrase inhibitors |
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/25/2005 | CA2553630A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 08/24/2005 | EP1566446A1 beta-1,4-MANNOBIOSE-CONTAINING COMPOSITION |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565481A1 Antiviral nucleoside derivatives |
| 08/24/2005 | EP1565470A2 Process for the preparation of ganciclovir |
| 08/24/2005 | EP1565461A2 Antibacterial substituted cyanomethyl(ene)piperidinophenyl oxazolidinones, process for their preparation, and pharmaceutical compositions containing them |
| 08/24/2005 | EP1565430A1 Biguanide and dihydrotriazine derivatives |
| 08/24/2005 | EP1565213A2 Treatment of prion-induced diseases by administration of anti-prion antibodies |
| 08/24/2005 | EP1565211A2 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 08/24/2005 | EP1565201A1 Methods of administering dalbavancin for treatment of bacterial infections |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565195A1 Anticancer or antiviral composition |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565080A2 Novel immunogenic proteins of leptospira |
| 08/24/2005 | EP1478770A4 Screening method for orthopoxvirus antivirals |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1356733B1 Pesticidal and antiparasitic compositions |
| 08/24/2005 | EP1263742B1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/24/2005 | EP1254146B1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1143925B1 Topical composition comprising n-acetylglucosamine |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | EP0804436B1 Guanine derivative |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0681483B1 Compositions and methods for delivery of genetic material |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659436A Method for isolating ligands |
| 08/24/2005 | CN1659281A Antiviral therapy on the basis of RNA interference |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1659178A 6, 11 bicyclic erythromycin derivatives |
| 08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659148A Aryloximes |